Table of Content

1 Markets: Industry Outlook
1.1 Trends: Current and Future Impact Assessment
1.1.1 Emerging Gene and Cell Therapies
1.1.2 Single-use Bioprocessing Equipment
1.1.3 Trend Toward Personalized Medicine
1.2 Supply Chain Overview
1.2.1 Value chain Analysis
1.2.2 Market Map
1.2.3 Cost of Manufacturing in CDMO/gm Forecast
1.3 Patent Analysis
1.3.1 Awaited Technological Developments
1.3.2 Patent Filing Trend by Country, by Year
1.3.3 Patent Filing Trend by Country, by Country
1.4 Regulatory Landscape
1.5 Prodution Capacity
1.6 Factors Considered While Outsourcing To CDMO
1.7 Impact analysis for key global events- covid19, Russia/Ukraine or Middle East crisis
1.8 Market Dynamics Overview
1.8.1 Market Drivers
1.8.2 Market Restraints
1.8.3 Market Opportunities

2 Application
2.1 Application Segmentation
2.2 Application Summary
2.3 Global Biologiv CDMO Market (by Cell Type)
2.3.1 Mammalian
2.3.2 Non-mammalian

3 Product
3.1 Product Segmentation
3.2 Product Summary
3.3 Global Biologics CDMO Market (by Product Type)
3.3.1 Biologics
3.3.1.1 Monoclonal Antibodies
3.3.1.2 Recombinant Proteins
3.3.1.3 Antisense and Molecular Therapy
3.3.1.4 Vaccines
3.3.1.5 Other Biologics
3.3.2 Biosimilars

4 Region
4.1 Regional Summary
Table: Biologics CDMO Market, By Region, ($ Million), 2022-2033
4.2 Drivers and Restraints
4.3 North America
Key Market Participants in North America
Business Drivers
Business Challenges
4.3.1 Application
Table: North America Biologics CDMO Market, By Cell Type ($ Million), 2022-2033
4.3.2 Product
Table: North America Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.3.3 North America (by Country)
4.3.3.1 U.S.
Table: U.S. Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: U.S. Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.3.3.2 Canada
Table: U.S. Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: U.S. Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.4 Europe
Key Market Participants in Europe
Business Drivers
Business Challenges
4.4.1 Application
Table: Europe Biologics CDMO Market, By Cell Type ($ Million), 2022-2033
4.4.2 Product
Table: Europe Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.4.3 Europe (by Country)
4.4.3.1 U.K.
Table: U.K.Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: U.K. Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.4.3.2 Germany
Table: Germany Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: Germany Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.4.3.3 Italy
Table: Italy Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: Italy Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.4.3.4 France
Table: France Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: France Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.4.3.5 Spain
Table: Spain Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: Spain Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.4.3.6 Rest of Europe
Table: Rest of Europe Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: Rest of Europe Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.5 Asia Pacific
Key Market Participants in Asia Pacific
Business Drivers
Business Challenges
4.5.1 Application
Table: Europe Biologics CDMO Market, By Cell Type ($ Million), 2022-2033
4.5.2 Product
Table: Europe Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.5.3 Asia Pacific (by Country)
4.5.3.1 China
Table: China Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: China Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.5.3.2 Japan
Table: Japan Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: Japan Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.5.3.3 India
Table: India Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: India Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.5.3.4 Australia
Table: Australia Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: Australia Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.5.3.5 Rest of APAC
Table: Rest of APAC Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: Rest of APAC Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.6 Latin America
Key Market Participants in Latin America
Business Drivers
Business Challenges
4.6.1 Application
Table: Latin America Biologics CDMO Market, By Cell Type ($ Million), 2022-2033
4.6.2 Product
Table: Latin America Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.6.3 Latin America (by Country)
4.6.3.1 Brazil
Table: Brazil Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: Brazil Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.6.3.2 Mexico
Table: Mexico Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: Mexico Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.6.3.3 Rest of Latin America
Table: Rest of Latin America Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: Rest of Latin America Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.7 MEA
Key Market Participants in MEA
Business Drivers
Business Challenges
4.7.1 Application
Table: MEA Biologics CDMO Market, By Cell Type ($ Million), 2022-2033
4.7.2 Product
Table: MEA Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.7.3 MEA (by Country)
4.7.3.1 Saudi Arabia
Table: Saudi Arabia Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: Saudi Arabia Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.7.3.2 U.A.E.
Table: U.A.E. Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: U.A.E. Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
4.7.3.3 Rest of MEA
Table: Rest of MEA Biologics CDMO Market Market, By Cell Type ($ Million), 2022-2033
Table: Rest of MEA Biologics CDMO Market Market, By Product Type ($ Million), 2022-2033
5 Markets - Competitive Landscape & Company Profiles
5.1 Competitive Landscape
5.2 Company Profile
5.2.1 Boehringer Ingelheim Group
5.2.1.1 Company Overview
5.2.1.1.1 Role of Boehringer Ingelheim Group in Biologics CDMO Market
5.2.1.1.2 Product Portfolio
5.2.1.2 Business Strategies
5.2.1.3 Corporate Strategies
5.2.1.4 Analyst View
5.2.2 Lonza Group
5.2.2.1 Company Overview
5.2.2.1.1 Role of Lonza Group in Biologics CDMO Market
5.2.2.1.2 Product Portfolio
5.2.2.2 Business Strategies
5.2.2.3 Corporate Strategies
5.2.2.4 Analyst View
5.2.3 Samsung Biologics
5.2.3.1 Company Overview
5.2.3.1.1 Role of Samsung Biologics in Biologics CDMO Market
5.2.3.1.2 Product Portfolio
5.2.3.2 Business Strategies
5.2.3.3 Corporate Strategies
5.2.3.4 Analyst View
5.2.4 NOVARTIS AG
5.2.4.1 Company Overview
5.2.4.1.1 Role of NOVARTIS AG in Biologics CDMO Market
5.2.4.1.2 Product Portfolio
5.2.4.2 Business Strategies
5.2.4.3 Corporate Strategies
5.2.4.4 Analyst View
5.2.5 Toyobo Co. Limited
5.2.5.1 Company Overview
5.2.5.1.1 Role of Toyobo Co. Limited Group in Biologics CDMO Market
5.2.5.1.2 Product Portfolio
5.2.5.2 Business Strategies
5.2.5.3 Corporate Strategies
5.2.5.4 Analyst View
5.2.6 Parexel International Corporation
5.2.6.1 Company Overview
5.2.6.1.1 Role of Parexel International Corporation in Biologics CDMO Market
5.2.6.1.2 Product Portfolio
5.2.6.2 Business Strategies
5.2.6.3 Corporate Strategies
5.2.6.4 Analyst View
5.2.7 Catalent Inc.
5.2.7.1 Company Overview
5.2.7.1.1 Role of Catalent Inc. in Biologics CDMO Market
5.2.7.1.2 Product Portfolio
5.2.7.2 Business Strategies
5.2.7.3 Corporate Strategies
5.2.7.4 Analyst View
5.2.8 Binex Co. Limited
5.2.8.1 Company Overview
5.2.8.1.1 Role of Binex Co. Limited in Biologics CDMO Market
5.2.8.1.2 Product Portfolio
5.2.8.2 Business Strategies
5.2.8.3 Corporate Strategies
5.2.8.4 Analyst View
5.2.9 AGC Biologics
5.2.9.1 Company Overview
5.2.5.1.1 Role of AGC Biologics in Biologics CDMO Market
5.2.5.1.2 Product Portfolio
5.2.9.2 Business Strategies
5.2.9.3 Corporate Strategies
5.2.9.4 Analyst View
5.2.10 AbbVie Contract Manufacturing
5.2.10.1 Company Overview
5.2.10.1.1 Role of AbbVie Contract Manufacturing in Biologics CDMO Market
5.2.10.1.2 Product Portfolio
5.2.10.2 Business Strategies
5.2.10.3 Corporate Strategies
5.2.10.4 Analyst View